Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
3
×
crispr
3
×
life sciences
national blog main
national top stories
san francisco blog main
san francisco top stories
biogen
biotech
boston top stories
boulder/denver blog main
boulder/denver top stories
deals
detroit blog main
detroit top stories
fda
gene editing
indiana blog main
indiana top stories
ipo
national
new york blog main
new york top stories
novartis
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
startups
texas blog main
texas top stories
vc
venture capital
wisconsin blog main
wisconsin top stories
2025
abbvie
ad-comm
What
bio
years
3
×
crispr
ipo
medicines
roundup
acquisitions
allogene
announced
cancer
ceo
collabs
covid
create
daniel
deal
diagnostic
diseases
diversity
editing
fix
gene
gilead
gilead’s
heats
help
high
hot
human
immunotherapy
introduce
investors
juno
launches
million
month
nearly
new
o’day
plans
Language
unset
Current search:
crispr
×
years
×
" boston blog main "
×
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
5 years ago
CRISPR Diagnostic Race Heats Up as Sherlock Bio Launches With $35M
@xconomy.com
5 years ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More